- cafead   Mar 24, 2022 at 11:53: AM
via Hookipa Pharma CEO Joern Aldag is betting on brighter days for biotech. With Hookipa’s stock stuck in the doldrums, Aldag is waiving 50% of his salary over the first half of the year in return for shares in a show of confidence in the company.
article source
article source